semaglutide euglycemic dka SGLT2 Inhibitor-induced Diabetic Ketoacidosis EUGLYCEMIC DKA FROM AN SGLT2
Description
[DOI] [PubMed] [Google Scholar] 91.Maselli D.B., Camilleri M

The narration is easy to follow and never felt too clinical

With the emergence of longer-acting and more potent GLP-1RAs such as semaglutide, one might assume that these compounds translate into increased efficacy in BAD compared with liraglutide

Researchers reported 54.9 per cent greater preservation of lean mass in the combination group, with an additional 1.9 kilograms of lean mass retained
Existing CVOT subgroup analyses already provide a basis for this, consistently showing greater benefits in patients with established ASCVD compared to those in a primary prevention setting [51]

Integrating the two workforces, moving everyone over to Bagsvrd at Novo's campus, completing paperwork, and a million other things had to be done
